Identification of metastatic papillary thyroid carcinoma in FNA specimens using thyroid peroxidase immunohistochemistry

被引:9
作者
Shield, P. W. [1 ,2 ]
Crouch, S. J. [3 ]
Papadimos, D. J. [1 ,3 ]
Walsh, M. D. [3 ]
机构
[1] Queensland Univ Technol, Sch Biomed Sci, Brisbane, Qld, Australia
[2] Sullivan Nicolaides Pathol, Cytol Dept, Brisbane, Qld, Australia
[3] Sullivan Nicolaides Pathol, Histopathol Dept, Brisbane, Qld, Australia
关键词
cytology; fine needle aspiration; immunohistochemistry; metastatic; thyroid papillary carcinoma; thyroid peroxidase; FINE-NEEDLE-ASPIRATION; TRANSCRIPTION FACTOR-I; LYMPH-NODE METASTASES; DIFFERENTIAL-DIAGNOSIS; THYROGLOBULIN; CANCER; CYTOLOGY; TUMORS; GALECTIN-3; PITFALL;
D O I
10.1111/cyt.12531
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
IntroductionWe evaluated immunohistochemical staining for thyroid peroxidase (TPO), a glycoprotein found in the apical plasma membrane of thyroid follicular cells, as a marker for metastatic PTC in FNA samples and compared results with thyroglobulin (Tg) and thyroid transcription factor 1 (TTF1) staining. MethodsCell block sections prepared from 100 FNA specimens were stained with a rabbit monoclonal antibody to TPO (EP159). The FNAs included 64 metastatic malignancies from non-thyroid primary sites, including 18 lung, and 36 cases of thyroid tumours (29 PTC, six cases of medullary thyroid carcinoma and one thyroid anaplastic carcinoma). Thyroid tumours were stained with TTF1 and Tg in addition to TPO. All cases of metastatic lung carcinoma also had TTF-1 staining results. ResultsTPO staining was negative in all non-thyroid malignancies. Ninety percent (26/29) of PTC were positive. All positive cases showed strong cytoplasmic staining, although 54% (14/26) showed positivity in less than half of the cells. By comparison, Tg staining of TPC cases was present in 62% and TTF-1 in 100%. In addition to showing higher sensitivity, interpretation of staining results with TPO was generally easier with than Tg. All metastatic lung adenocarcinomas were positive for TTF-1 and TPO negative. The six medullary cancers showed positivity in 17%, 0% and 83% with TPO, Tg and TTF-1, respectively. ConclusionsTPO (mAb EP159) may be a useful addition to immunohistochemical panels for FNA specimens where metastatic PTC is a consideration, particularly in cases where metastatic lung carcinoma features in the differential diagnosis. Ninety percent of metastatic papillary thyroid carcinomas in cell block specimens from lymph node aspirates were positive for thyroid peroxidase. This was more sensitive than thyroglobulin and more specific than TTF-1, which also stained all metastatic lung adenocarcinomas.
引用
收藏
页码:227 / 232
页数:6
相关论文
共 50 条
  • [41] Utility of GATA3 Immunohistochemistry for Diagnosis of Metastatic Breast Carcinoma in Cytology Specimens
    Braxton, David R.
    Cohen, Cynthia
    Siddiqui, Momin T.
    DIAGNOSTIC CYTOPATHOLOGY, 2015, 43 (04) : 271 - 277
  • [42] Update on the Cytologic Features of Papillary Thyroid Carcinoma Variants
    Pusztaszeri, Marc
    Auger, Manon
    DIAGNOSTIC CYTOPATHOLOGY, 2017, 45 (08) : 714 - 730
  • [43] Paired Box Gene 8, HBME-1, and Cytokeratin 19 Expression in Preoperative Fine-Needle Aspiration of Papillary Thyroid Carcinoma Diagnostic Utility
    Schmitt, Alessandra C.
    Cohen, Cynthia
    Siddiqui, Momin T.
    CANCER CYTOPATHOLOGY, 2010, 118 (04) : 196 - 202
  • [44] Relevance of rosette patterns in variants of papillary thyroid carcinoma
    Dell'Aquila, Marco
    Musarra, Teresa
    Fiorentino, Vincenzo
    Brunelli, Chiara
    De Marco, Costanza
    Raffaelli, Marco
    Traini, Emanuela
    Lombardi, Celestino Pio
    Fadda, Guido
    Larocca, Luigi Maria
    Pantanowitz, Liron
    Rossi, Esther Diana
    CYTOPATHOLOGY, 2020, 31 (06) : 533 - 540
  • [45] Concomitant papillary thyroid carcinoma and Hashimoto's thyroiditis
    Liu, LH
    Bakhos, R
    Wojcik, EM
    SEMINARS IN DIAGNOSTIC PATHOLOGY, 2001, 18 (02) : 99 - 103
  • [46] TROP-2 immunohistochemistry: a highly accurate method in the differential diagnosis of papillary thyroid carcinoma
    Bychkov, Andrey
    Sampatanukul, Pichet
    Shuangshoti, Shanop
    Keelawat, Somboon
    PATHOLOGY, 2016, 48 (05) : 425 - 433
  • [47] Impact of reclassifying noninvasive follicular variant of papillary thyroid carcinoma on the risk of malignancy in The Bethesda System for Reporting Thyroid Cytopathology
    Faquin, William C.
    Wong, Lawrence Q.
    Afrogheh, Amir H.
    Ali, Syed Z.
    Bishop, Justin A.
    Bongiovanni, Massimo
    Pusztaszeri, Marc P.
    VandenBussche, Christopher J.
    Gourmaud, Jolanta
    Vaickus, Louis J.
    Baloch, Zubair W.
    CANCER CYTOPATHOLOGY, 2016, 124 (03) : 181 - 187
  • [48] Follicular Variant of Papillary Thyroid Carcinoma: Accuracy of FNA Diagnosis and Implications for Patient Management
    Berrin Ustun
    David Chhieng
    Manju L. Prasad
    Elizabeth Holt
    Lynwood Hammers
    Tobias Carling
    Robert Udelsman
    Adebowale J. Adeniran
    Endocrine Pathology, 2014, 25 : 257 - 264
  • [49] Ultrasonographical, clinical and histopathological features of 1264 nodules with papillary thyroid carcinoma and microcarcinoma based on tumor size
    Seyrek, Neslihan Cuhaci
    Baser, Husniye
    Topaloglu, Oya
    Ozdemir, Didem
    Kilicarslan, Aydan
    Ersoy, Reyhan
    Cakir, Bekir
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2020, 64 (05): : 533 - 541
  • [50] Uncommon BRAF Mutations in the Follicular Variant of Thyroid Papillary Carcinoma: New Insights
    Rossi, Esther Diana
    Martini, Maurizio
    Bizzarro, Tommaso
    Capodimonti, Sara
    Cenci, Tonia
    Lombardi, Celestino Pio
    Pontecorvi, Alfredo
    Fadda, Guido
    Larocca, Luigi Maria
    CANCER CYTOPATHOLOGY, 2015, 123 (10) : 593 - 602